We take a bespoke approach to all our trials. We understand every therapeutic area is different. We perform careful review of trial design, inclusion/exclusion criteria, and review of the specific needs and/or study participation challenges expressed from diverse patients and providers to do our part to reduce barriers and support clinical trial equity.
This case study highlights the success we had in providing a flexible approach in a COVID19 study, to a non-for-profit sponsor, to quickly access a more representative patient population.
Download the full case study for more insight.
Please contact us at sales@science37.com to learn more about how we enable diversity in clinical trials.